Q32 Bio Inc. (QTTB)
NASDAQ: QTTB · Real-Time Price · USD
15.15
-0.23 (-1.50%)
Jul 24, 2026, 4:00 PM EDT - Market closed
Q32 Bio Market Cap
Q32 Bio has a market cap or net worth of $256.89 million as of July 24, 2026. Its market cap has increased by 800.03% in one year.
Market Cap
256.89M
Enterprise Value
219.78M
1-Year Change
800.03%
Ranking
Category
Stock Price
$15.15
ChartMarket Cap Chart
Since March 26, 2024, Q32 Bio's market cap has increased from $199.19M to $256.89M, an increase of 28.97%. That is a compound annual growth rate of 11.54%.
| Date | Market Cap | % Change |
|---|---|---|
| Jul 24, 2026 | 256.89M | 528.85% |
| Dec 31, 2025 | 40.85M | -2.51% |
| Dec 31, 2024 | 41.90M | -78.96% |
| Mar 26, 2024 | 199.19M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Bicycle Therapeutics | 270.17M |
| SAB Biotherapeutics | 268.39M |
| Sol-Gel Technologies | 267.93M |
| Agenus | 267.62M |
| Outlook Therapeutics | 262.73M |
| Lineage Cell Therapeutics | 256.78M |
| InflaRx | 256.29M |
| Niagen Bioscience | 256.19M |